The main psychoactive component in magic mushrooms, psilocybin, has passed its first clinical safety trial. The drug is now closer to becoming a licensed treatment for depression. Should this happen,...
19 December 2019
16 December 2019
Many people take for granted that the medication they have been prescribed by their physician will adequately treat or cure their ailment. Yet the reality is that a large number...
21 November 2019
Functional Service Providers: A flexible trial staffing model that’s capable of taking on biomarker data management
As large pharma, biotech, and medical device organizations feel the economic pinch of escalating cost, stricter regulations, and fiercer competition, many seek new ways to cut the costs of development...
28 October 2019
Medical device and diagnostic solutions: A life cycle development model that moves your device ahead of the game
The medical device and diagnostic (MDD) industry is experiencing a transformational era due to huge advances in technologies such as AI, robotics, mobile apps, combination products and patient-enabled diagnostic tests.
9 October 2019
How mobile health, local sample collections and virtual models are redefining where clinical trials happen
We live in an era where there is an expectation of immediate results. We connect with other people and with companies via the web, mobile apps, internet chats – all...
22 September 2019
As clinical trials get more complex and pressures to deliver increase, trial sponsors are seeking more efficient ways to execute studies.
19 August 2019
It’s a well-cited fact that the greatest challenge facing clinical trials today is patient recruitment and retention.